surmount 2 tirzepatide 3 once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase trial Nutritional status with tirzepatide in – surmount-1 tirzepatide non-diabetic obesity trial
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4


























